Select a product:
Infectious disease
Bone and mineral metabolism
Endocrinology
Oncology
Liaison ®
Spq protein
Autoimmunity
Therapeutic drug monitoring
Cns
International Catalog
ANTI-PHOSPHOLIPIDE ANTIBODIES - ELISA
ETI-Cardiolipin Screen |
N0057/96 Wells |
Intended use |
For the detection of Cardiolipin IgM/IgG Antibodies. |
Method |
ELISA |
Controls included |
Two Levels (positive, negative) |
Incubations |
30 min + 30 min/RT |
Chromogen/Substrate |
TMB |
Feature & benefits |
Simple and Objective. Proven Clinical Utility. |
Conjugates |
HRP |
Reading |
Spectrophotometric |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
ETI-Cardiolipin IgG |
N0059/96 Wells |
Intended use |
For the quantitative determination of Cardiolipin IgG Antibodies. |
Method |
ELISA |
Controls included |
Two Levels (positive, negative) |
Calibrators |
4 (0-91 GPL/mL) |
Incubations |
30 min + 30 min/RT |
Chromogen/Substrate |
TMB |
Feature & benefits |
Simple and Objective. Proven Clinical Utility. |
Conjugates |
HRP |
Reading |
Spectrophotometric |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
ETI-Cardiolipin IgM |
N0058/96 Wells |
Intended use |
For the quantitative determination of Cardiolipin IgM Antibodies. |
Method |
ELISA |
Controls included |
Two Levels (positive, negative) |
Calibrators |
4 (0-92 GPL/mL) |
Incubations |
30 min + 30 min/RT |
Chromogen/Substrate |
TMB |
Feature & benefits |
Simple and Objective. Proven Clinical Utility. |
Conjugates |
HRP |
Reading |
Spectrophotometric |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
ETI-Cardiolipin IgA |
N0079/96 Wells |
Intended use |
For the quantitative determination of Cardiolipin IgA Antibodies. |
Method |
ELISA |
Controls included |
Two Levels (positive, negative) |
Calibrators |
4 (0-120 APL/mL) |
Incubations |
30 min + 30 min/RT |
Chromogen/Substrate |
TMB |
Feature & benefits |
Simple and Objective. Proven Clinical Utility. |
Conjugates |
HRP |
Reading |
Spectrophotometric |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
ETI-Beta2 Glycoprotein I IgG |
N0056/96 Wells |
Intended use |
For the quantitative determination of β2 -Glycoprotein I IgG Antibodies. |
Method |
ELISA |
Controls included |
Two Levels (positive, negative) |
Calibrators |
4 (0-100 SG U/mL) |
Incubations |
30 min + 30 min/RT |
Chromogen/Substrate |
TMB |
Feature & benefits |
Simple and Objective. Proven Clinical Utility. |
Conjugates |
HRP |
Reading |
Spectrophotometric |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
ETI-Beta2 Glycoprotein I IgM |
N0077/96 Wells |
Intended use |
For the quantitative determination of β2 -Glycoprotein I IgM Antibodies. |
Method |
ELISA |
Controls included |
Two Levels (positive, negative) |
Calibrators |
4 (0-100 SM U/mL) |
Incubations |
30 min + 30 min/RT |
Chromogen/Substrate |
TMB |
Feature & benefits |
Simple and Objective. Proven Clinical Utility. |
Conjugates |
HRP |
Reading |
Spectrophotometric |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
ETI-Beta2 Glycoprotein I IgA |
N0081/96 Wells |
Intended use |
For the quantitative determination of β2 -Glycoprotein I IgA Antibodies. |
Method |
ELISA |
Controls included |
Two Levels (positive, negative) |
Calibrators |
4 (0-100 SA U/mL) |
Incubations |
30 min + 30 min/RT |
Chromogen/Substrate |
TMB |
Feature & benefits |
Simple and Objective. Proven Clinical Utility. |
Conjugates |
HRP |
Reading |
Spectrophotometric |
Sample type |
Serum |
Sample size |
100 µL (1:101) |


